Sublimity Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Sublimity Therapeutics's estimated annual revenue is currently $2.4M per year.
- Sublimity Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Sublimity Therapeutics has 12 Employees.
- Sublimity Therapeutics grew their employee count by -20% last year.
Sublimity Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $28.7M | 143 | 7% | N/A | N/A |
#2 | $4.8M | 23 | 5% | $203.4M | N/A |
#3 | $26.7M | 133 | N/A | N/A | N/A |
#4 | $14.9M | 74 | 7% | N/A | N/A |
#5 | $2.4M | 12 | -20% | N/A | N/A |
#6 | $28.9M | 144 | 1% | N/A | N/A |
#7 | $16.7M | 83 | 5% | N/A | N/A |
#8 | $17.7M | 88 | 4% | N/A | N/A |
#9 | $49.4M | 246 | 4% | N/A | N/A |
#10 | $106.1M | 528 | 1% | N/A | N/A |
What Is Sublimity Therapeutics?
Sublimity Therapeutics is a clinical-stage biotechnology company dedicated to identifying and developing meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases. Led by a team of industry innovators and leveraging our Single-Multiple Pill (SmPillￃﾂￂﾮ) technology, we are advancing a diverse pipeline of oral small molecules that have the potential to make important contributions to human health. Our lead asset ST-0529 is currently being evaluated in the AURORA (CYC-202) Study, a Phase 2b clinical trial for moderate to severe Ulcerative Colitis.
keywords:N/A
N/A
Total Funding
12
Number of Employees
$2.4M
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sublimity Therapeutics News
... Nestle, Arena Pharmaceuticals, Gilead Sciences, Galapagos, MSD, Celltrion, Sublimity Therapeutics, Sandoz, Abbott Laboratories, and Athos Therapeutics.
Groundbreaking therapies for hard-to-treat illnesses, ... The very first award went to Sigmoid Pharma now Sublimity Therapeutics.
Other Companies in Dublin
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 12 | 20% | N/A |
#2 | $1.8M | 12 | -29% | N/A |
#3 | $1M | 12 | -20% | N/A |
#4 | $1.5M | 12 | -8% | N/A |
#5 | $1M | 12 | -25% | N/A |